Our catalog comprises an extensive collection of annotated and characterized XenoSTART Patient Derived Xenograft (XPDX) Models.
Data from each model includes clinical treatment history and outcome, sequencing data, and drug sensitivity information.
What Makes Our Models Unique
XenoSTART patient-derived xenograft (XPDX) models are established from patients treated at The START Center, a global oncology treatment and research organization. Models from chemo-naïve and pretreated patients in over twenty-five indications are available for in vivo evaluation or licensing.